|
Drug Improves Mobility for Some MS Patients Saturday, February 28, 2009 - Anuradha Menon Home >> Headlines >> Medicine   
|
|
The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The Lancet. “This study indicates that fampridine could represent an important new way to treat multiple sclerosis and perhaps become the first drug to improve certain symptoms of the disease,” said neurologist Andrew Goodman, M.D. (source: urmc.rochester.edu)
|
|
|
|
| Related News |
|
Viruses may Defeat Bacteria |
|
Getting Out of the Loop of Alzheimer's Disease |
| Related Pictures |
|
Improving Speech Intelligibility |
|
ReWalk – Robotic Legs |
| Related Articles |
|
Mind Controlled Bionic Limbs |
|
Shedding Light on Blindness |
